You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Express Scripts
Merck
Harvard Business School
McKinsey

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

Hikma Intl Pharms Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HIKMA INTL PHARMS, and when can generic versions of HIKMA INTL PHARMS drugs launch?

HIKMA INTL PHARMS has forty-three approved drugs.

There are five US patents protecting HIKMA INTL PHARMS drugs.

Summary for Hikma Intl Pharms
US Patents:5
Tradenames:30
Ingredients:30
NDAs:43

Drugs and US Patents for Hikma Intl Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms DIGOXIN digoxin TABLET;ORAL 077002-002 Oct 30, 2007 AB RX No No   Start Trial   Start Trial
Hikma Intl Pharms ISONIAZID isoniazid TABLET;ORAL 087425-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Hikma Intl Pharms DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062396-002 Nov 7, 1984 AB RX No No   Start Trial   Start Trial
Hikma Intl Pharms CAPTOPRIL captopril TABLET;ORAL 074505-002 Feb 13, 1996 AB RX No No   Start Trial   Start Trial
Hikma Intl Pharms AMINOPHYLLINE aminophylline TABLET;ORAL 085003-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Hikma Intl Pharms CAPTOPRIL captopril TABLET;ORAL 074505-004 Feb 13, 1996 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for HIKMA INTL PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 0.6 mg ➤ Subscribe 2016-06-10
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Johnson and Johnson
Moodys
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.